1 Division of Nephrology, Université Catholique de Louvain Medical School, B-1200 Brussels, Belgium; and 2 Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cl channels are
involved in a range of functions, including regulation of cell volume
and/or intracellular pH, acidification of intracellular vesicles, and
vectorial transport of NaCl across many epithelia. Numerous
Cl
channels have been identified in the kidney, based on
single-channel properties such as conductance, anion selectivity,
gating, and response to inhibitors. The molecular counterpart of many
of these Cl
channels is still not known. This review will
focus on gene-targeted mouse models disrupting two structural classes
of Cl
channels that are relevant for the kidney: the CLC
family of voltage-gated Cl
channels and the CFTR.
Disruption of several members of the CLC family in the mouse provided
useful models for various inherited diseases of the kidney, including
Dent's disease and diabetes insipidus. Mice with disrupted CFTR are
valuable models for cystic fibrosis (CF), the most common autosomal
recessive, lethal disease in Caucasians. Although CFTR is expressed in
various nephron segments, there is no overt renal phenotype in CF.
Analysis of CF mice has been useful to identify the role and potential
interactions of CFTR in the kidney. Furthermore, observations made in
CF mice are potentially relevant to all other models of
Cl
channel knockouts because they emphasize the
importance of alternative Cl
pathways in such models.
Bartter's syndrome; bicarbonate transport; chloride channel; cystic fibrosis transmembrane conductance regulator; Dent's disease; endocytosis; nephrogenic diabetes insipidus; vesicular acidification
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
IN PLANTS AND ANIMAL TISSUES,
Cl is the most abundant anion and Cl
transporters are involved in a range of physiological processes, including regulation of cell volume, regulation of intracellular pH,
acidification of intracellular vesicles, and transepithelial transport
(79). Cl
channels are involved in the
vectorial transport of NaCl and fluid across many epithelia. In the
kidney, most of the Cl
filtered is reabsorbed, and this
process involves different mechanisms operating in the apical and
basolateral membranes of tubular epithelial cells. Several
Cl
transporters use the energy stored in transmembrane
gradients of other ions to move Cl
across the apical
plasma membrane often against its electrochemical gradient.
Cl
channels located in the basolateral membrane mediate
net Cl
efflux from the cell and participate in NaCl
reabsorption by the nephron (19). In addition to the
specialized, NaCl-reabsorbing function, passive Cl
diffusion through Cl
channels is involved in cell volume
regulation, for which the parallel movement of Cl
and
K+ through swelling-activated channels results in a
reduction of intracellular osmolytes when cells are exposed to external
hypotonicity (96). Transport of Cl
through
Cl
/HCO
/HCO
conductance in endosomal vesicles is indeed necessary both for endosomal acidification (113) and normal progression and
recycling along the endocytic apparatus (182).
Numerous Cl channels have been identified in all segments
of the nephron, based on single-channel properties such as conductance, anion selectivity, gating, and response to inhibitors
(19). The molecular counterpart of many Cl
channels in the kidney is still not known, and this review will focus on two structural classes of Cl
channels that have
been cloned and sequenced: the CLC channels family and the CFTR.
Mutations of two members of the CLC Cl
channels family
(ClC-5 and ClC-Kb) in humans lead to two distinct inherited diseases of
the kidney: Dent's disease (102), and Bartter's syndrome
(155), respectively. These two human diseases are
completed by the diabetes insipidus symptoms in the ClC-K1 knockout
mouse (111). Loss-of-function mutations affecting CFTR are
responsible for cystic fibrosis (CF), the most common autosomal
recessive, lethal disease in Caucasians (186). We will
detail how phenotypical analyses in mouse models and human diseases
have provided new insights into the diverse roles played by
Cl
channels in the kidney (Table
1).
|
![]() |
THE CLC FAMILY OF VOLTAGE-GATED CL![]() |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Several members of the CLC family of voltage-gated
Cl channels have been identified in the mammalian kidney
(for review, see Refs. 79 and 183). The first member of
this family, ClC-0, was isolated by Jentsch and colleagues
(80) from the electric organ of the Torpedo. To
date, at least nine different CLC genes, highly conserved during
evolution, have been identified in mammals (79).
Biochemical studies performed chiefly on ClC-0 suggested that CLC
channels have a double-barelled, homodimeric configuration, with each
CLC subunit containing its own pore (105). An alternative model for ClC-1 was proposed, based on a single pore composed of two
subunits (49). Different numbers of transmembrane domains of CLC channels have also been suggested (50, 144). The
two issues have been clarified by the recent crystallization of two bacterial CLC proteins at 3.0-Å resolution (46). The CLC
channels are homodimers with a double-barreled configuration. Each
subunit has its own pore and contains 18
-helices, 17 of which are
inserted into the membrane. Each subunit is composed of two halves that are structurally related but have opposite orientations within the
membrane. This antiparallel orientation brings together residues that
will form the Cl
ion selectivity filter
(46).
With the exception of ClC-1, which is predominantly expressed in skeletal muscle, all other CLC channels have been detected in the kidney. Three members of the CLC family (ClC-K1, ClC-Kb, and ClC-5) were found to be involved in kidney disease in either humans or mice. The broadly expressed ClC-2 channel was postulated to have a role in early nephrogenesis (73), but its disruption in mice did not confirm this hypothesis (21).
ClC-K1 and Nephrogenic Diabetes Insipidus
ClC-K1 and its human homologue ClC-Ka. The ability to concentrate urine is an essential function of the mammalian kidney, which is achieved by water reabsorption in the collecting duct (CD) according to the osmolar gradient across the tubule. In response to increased plasma osmolality, the neurohypophysal antidiuretic hormone arginine vasopressin (AVP) is released and binds to its specific V2 receptors (V2R) located in the principal cells of the CD. The binding of AVP to V2R activates the stimulatory GTP-binding protein Gs, which in turn stimulates adenylate cyclase. The subsequent increase in the cytosolic levels of cAMP leads to protein kinase A activation, phosphorylation of the water channel aquaporin-2 (AQP2), and, eventually, its insertion into the apical membrane (90). On the other hand, urine concentration necessitates the generation of an osmotic gradient extending from the corticomedullary junction to the inner medulla. In the outer medulla, the gradient is generated by the countercurrent multiplication of the transepithelial reabsorption of NaCl in the thick ascending limb (TAL) of the loop of Henle (56). Both NaCl reabsorption and urea recycling play a crucial role in maintaining high interstitial osmolality in the inner medulla (110). Any disruption of the complex mechanism of urinary concentrating ability will potentially lead to diabetes insipidus, a clinical condition qualified as "central," if the urinary concentrating ability is corrected by the exogenous administration of AVP or an analog, or "nephrogenic," if the kidney remains unresponsive to AVP (118).
The inner medulla is characterized by a variable density of long-looped nephrons containing the thin ascending limb (tAL) of Henle's loop. The tAL has long been considered to play an important role by diluting urine and maintaining the hypertonicity of the interstitium through reabsorption of NaCl. In vitro perfusion studies showed that the tAL has the highest ClNephrogenic diabetes insipidus in the Clcnk1 knockout mouse.
The hypothesis that ClC-K1 is a major Cl channel
mediating transepithelial Cl
transport in tAL and thereby
participating in urinary concentration was confirmed by a mouse model
in which ClC-K1 had been deleted by homologous recombination
(111) (Fig. 1). There were
no apparent differences among Clcnk1
/
,
Clcnk1+/
, and
Clcnk1+/+ mice in survival, gross physical
appearance, and organ morphology. The plasma values of creatinine,
Na+, K+, and HCO
mice,
Clcnk1
/
mice showed a fivefold increase in
urine volume, coupled to a significant decrease in urine osmolality.
Water deprivation induced a 27% weight loss in
Clcnk1
/
mice compared with 12% weight loss
in Clcnk1+/+ and
Clcnk1+/
mice. These
manifestations were associated with a minimal increase in urine
osmolality after administration of the V2R agonist dDAVP, confirming
the clinical picture of nephrogenic diabetes insipidus. In vitro
microperfusion studies showed that establishment of a lumen-to-bath
Cl
gradient in the tAL did not yield a Cl
conductance in Clcnk1
/
mice, in contrast to
that observed in Clcnk1+/+ and
Clcnk1+/
mice (111).
|
ClC-K2/b and Bartter's Syndrome
ClC-K2 and its human homologue ClC-Kb.
ClC-K2 was isolated from rat kidney by using a PCR-based cloning
strategy (2). This Cl channel shares an
~80% amino acid identity with ClC-K1 and is also exclusively
expressed in the kidney (2). The human isoform ClC-Kb
(which is 95% identical to ClC-Ka) has also been identified in the
kidney (88). One homologue has been identified in the rabbit (rbClC-Ka) (196). The intrarenal distribution of
ClC-K2 is clearly distinct from that of ClC-K1. In situ hybridization with specific riboprobes directed against the nonhomologous
3'-untranslated regions of ClC-K1 and ClC-K2 demonstrated the absence
of colocalization between the two transcripts. It also showed abundant
expression of ClC-K2 in the distal convoluted tubule (DCT), connecting
tubule (CT), and cortical CD and moderate expression in the medullary TAL (192). The homology between ClC-K1 and ClC-K2 hampered
the generation of specific antibodies against ClC-K2 (172,
183), but the difficulty has been overcome by staining
Clcnk1
/
kidneys with an anti-ClC-K antibody
that recognizes both ClC-K1 and ClC-K2 (91). This study
confirmed that ClC-K2 is broadly expressed in the distal nephron,
including TAL, DCT, CT, and intercalated cells of the CD. In all these
locations, ClC-K2 is located in the basolateral membrane
(91).
Bartter's syndrome and mutations in ClC-Kb.
Although it was initially not possible to functionally express
ClC-Kb/K2 in X. laevis oocytes (88), its high
degree of sequence homology with other members of the CLC family
predicted that it likely plays a role in transepithelial transport of
Cl in the distal nephron. Even before the generation of a
ClC-Kb/K2 knockout mouse, Simon et al. (155) verified that
hypothesis by reporting mutations of the CLCNKB gene in
patients with Bartter's syndrome. Bartter's syndrome is an autosomal
recessive renal tubular disorder characterized by salt wasting,
hypokalemic alkalosis, and hypercalciuria (142). Because
the syndrome is similar to the action of the loop diuretic furosemide,
it was suggested that Bartter's syndrome results from impaired NaCl
reabsorption in the distal nephron/diluting segment of the loop of
Henle. Simon et al. (155-157) actually proved that
assertion by documenting three types of Bartter's syndromes: Bartter
type I (due to mutations in the apical
Na+-K+-2Cl
cotransporter NKCC2);
Bartter type II (due to mutations in the apical K+ channel
ROMK); or Bartter type III (due to mutations in the basolateral Cl
channel ClC-Kb). A fourth variant, that associates
Bartter's syndrome with sensorineural deafness, has recently been
linked to mutations in BSND, a gene that encodes barttin, an
integral membrane protein that acts as an essential
-subunit for
ClC-Ka and ClC-Kb Cl
channels (18, 48). This
remarkable collection of genetic and functional evidence puts ClC-Kb
and its crucial
-subunit barttin into a functional relationship with
the apical Na+-K+-2Cl
cotransporter and the ROMK K+ channel, suggesting a
mechanism byn which Cl
is taken up apically by the
cotransporter and exits basolaterally via ClC-Kb (Fig. 1).
ClC-5 and Dent's Disease
Identification and characterization of ClC-5.
The CLCN5 gene that codes for the ClC-5 Cl
channel was identified by positional cloning in families with Dent's
disease, an X-linked renal tubular disorder that includes
low-molecular-weight proteinuria, generalized PT dysfunction (renal
Fanconi syndrome), hypercalciuria, nephrocalcinosis, kidney stones, and
renal failure (51). ClC-5 encodes a 746-amino acid protein
and shares ~80% homology with ClC-3 (83) and ClC-4
(181). These three channels form a branch of the CLC
family with only ~30% amino acid identity with other branches of the
family (79). When ClC-5 is expressed in X. laevis oocytes (52, 102, 160) or in Chinese hamster ovary cells (52), it induces strong outwardly rectifying
Cl
currents that are inhibited by acidic extracellular
pH. The Cl
currents elicited by injection of ClC-5 in
X. laevis oocytes require voltages of +20 mV, a condition
rarely reached in most cells, except for the urinary bladder of the
amphibian Necturus (67). Because some CLC
channels require
-subunits to form heteromers (48), it
is possible that acting in combination with
-subunits could modify
this voltage dependence.
Mutations of CLCN5 and Dent's disease.
Mutations of CLCN5 were found in Dent's disease and three
other phenotypic variants referred to as X-linked recessive
nephrolithasis, X-linked recessive hypophosphataemic rickets, and the
idiopathic low-molecular-weight proteinuria of Japanese children
(70, 102, 103). Mutations of ClC-5 that are associated
with Dent's disease abolish or markedly reduce the Cl
currents elicited in heterologous expression systems (75,
101-103). Low-molecular-weight proteinuria represents the
most consistent manifestation of Dent's disease and is almost always
detected in female carriers (103, 135). In contrast, there
is considerable interfamilial and intrafamilial variability in other
manifestations of the disease, including hypercalciuria, PT solute
wasting, hypercalciuria, distal tubule disorders, and rickets
(141, 188, 194). There are no clear correlations between
the clinical phenotype of Dent's disease and the >35 mutations of
CLCN5 identified thus far (141, 194).
ClC-5 and endocytosis in the PT.
The expression of ClC-5 in PT cells and its colocalization with
H+- ATPase to subapical endosomes suggested that ClC-5
may have a role in the counterion transport mechanism that facilitates endosomal acidification (42, 62, 107), despite the fact
that its biophysical properties (outward rectification and inhibition by acidic pH) are apparently not ideal for such a role (52, 102). The endosomes form part of the megalin receptor-mediated endocytic pathway that reabsorbs proteins such as albumin and low-molecular-mass (<70 kDa) proteins [e.g.,
1-microglobulin,
2-microglobulin, vitamin
D binding protein (DBP), Clara cell protein (CC16)] that are freely
filtered and almost totally reabsorbed by PT cells (29).
It is well established that a Cl
conductance is necessary
for acidification of PT endosomes (9, 134) (Fig.
2). Luminal acidification of the
endosomes is required for the distribution and degradation of
internalized ligands in the endocytic pathway (182) and
for the progression of early endosomes to late endosomes/lysosomes
(7). Endosomal acidification is generated primarily by the
vacuolar H+-ATPase, with acidification increasing
progressively from endocytic vesicles and early endosomes to late
endosomes and, ultimately, lysosomes. The varying degree of endosomal
acidification depends on whether the electrogenic H+-ATPase
is antagonized by other transporters (e.g., by the electrogenic Na+ pump) or facilitated by a coupled Cl
conductance (113, 152). Although the exact nature of the
Cl
channels operating in endosomes remains undefined
(22, 143), it has been hypothesized that an impaired
acidification of the endosomal apparatus due to loss of function of
ClC-5 could affect endocytosis, thus causing the systematic occurrence
of low-molecular-weight proteinuria in Dent's disease (42, 62,
102). However, it is still unknown whether luminal acidification
is required for the formation of primary endocytic vesicles or whether
poor entry in the endocytic apparatus is a secondary defect, e.g., due
to inefficient recycling of a rate-limiting partner of the endocytic machinery.
|
ClC-5 in distal nephron segments.
In addition to PT cells, ClC-5 is also expressed in the intercalated
cells of the CD (42, 62, 122, 138) and, at least in human
and rat kidney, in the TAL (42, 107). In the
acid-secreting -type intercalated cells, ClC-5 colocalizes with
H+-ATPase in intracellular vesicles and apical plasma
membrane (42, 62, 138), and it could play a role in distal
urinary acidification (Fig. 1). However, this question remains
debatable, because urinary acidification is normal in the majority of
patients with Dent's disease (141, 188). The TAL is an
important site for regulated Ca2+ reabsorption
(142), and Silva et al. (154) recently showed that ClC-5 mRNA expression in the kidney is regulated by parathyroid hormone (PTH). Thus ClC-5 may play a role in Ca2+
homeostasis, although it remains unclear how an apparently
intracellular Cl
channel may participate in the positive
luminal potential that drives paracellular Ca2+
reabsorption in that nephron segment (142). Furthermore,
at variance with Bartter's syndrome (cf. Bartter's syndrome and
mutations in ClC-Kb), Dent's disease is not consistently
associated with hypercalciuria and is usually not associated with
clinical dehydration (141, 188).
Mouse models of ClC-5 disruption. The potential roles of ClC-5 in endocytosis and Ca2+ homeostasis have been substantiated by three distinct mouse models of disrupted ClC-5 expression (Table 1). Luyckx et al. (108) reported the first mouse model of reduced ClC-5 expression by a ribozyme approach, resulting in ~80% reduction in renal ClC-5 protein expression. The transgenic ribozyme-expressing mice showed no obvious phenotype except for a borderline hypercalciuria (that was found only in males), without PT dysfunction and low-molecular-weight proteinuria (108, 194). Of note, the hypercalciuria was prevented by a low-Ca2+ diet, suggesting a role for increased intestinal Ca2+ absorption (108).
Two groups have independently generated and characterized knockout mouse models for Dent's disease by targeted disruption of part of the exon 5 and/or exon 6 of Clcn5 (129, 184). The loss of ClC-5 mRNA and protein in the kidney of both Clcn5ClC-2 and the Kidney
ClC-2 was cloned by homology to ClC-1 (168). The ClC-2 Cl ![]() |
CFTR |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
CFTR and CF
The CFTR protein contains 1,480 amino acids and is a member of the ATP-binding cassette (ABC) transporters family. CFTR is composed of two transmembrane domains (TMD1 and TMD2) and two nucleotide-binding domains (NBD1 and NBD2), separated by a large, polar, regulatory (R) domain containing multiple phosphorylation sites (for a review, see Ref. 151). Mutations in the CF gene that encodes CFTR are responsible for CF, the most common autosomal recessive disease in Caucasians (37, 136, 186). CFTR is located primarily in the apical membrane of epithelial cells, where it provides a pathway for transepithelial ClIn addition to impaired Cl channel activity, a defect in
HCO
900 putative disease-causing mutations in the CF gene, there are a few
that are characterized by normal Cl
channel activity
(37). A recent study of 16 such mutations expressed in HEK
293 cells has shown that they are associated with a significant
alteration of HCO
-coupled HCO
CFTR in the Kidney
Numerous studies have identified CFTR in the mammalian kidney (159). CFTR mRNA is abundantly expressed in the cortex and outer medulla but much less in the inner medulla (116). Segmental analysis by RT-PCR showed that CFTR is expressed in all nephron segments, including PT, thin limbs of Henle, TAL, distal tubules, and CD (116). Immunostaining for CFTR has been detected in the apical domain of both proximal and distal tubules of the mature human kidney (36). CFTR is also expressed early in the embryonic human and rat kidney, with a transient upregulation in the ureteric bud during the late stage of branching morphogenesis (41, 72). This pattern of expression in the mammalian kidney is similar to that observed during branching morphogenesis in pancreas and lung (71). ClA splice variant of CFTR is expressed in rat and human kidney and shows distinct regulation during nephrogenesis (41, 72). This truncated CFTR variant lacks 145 bp of exons 13 and 14, resulting in a frameshift and a premature stop codon. The truncated, 75-kDa isoform (TNR-CFTR) contains the TMD1, NBD1, and R domains. It is functional when expressed in X. laevis oocytes, with single-channel properties very similar to full-length CFTR but less efficient processing and plasma membrane expression (116).
CFTR and Intracellular Organelles
In parallel with its role in apical membrane ClRenal Manifestations of CF
There is a striking discrepancy between the level of CFTR expression in the human kidney and the lack of clearly documented renal phenotype in CF patients (40, 136, 159, 186). Despite structural and obstructive changes in the vas deferens, epididymis, and seminal vesicles, which suggest that the CF disease process operates during the development of the mesonephric duct (171), CF patients do not show overt developmental abnormalities in the urinary excretory system. Children with CF may present dehydration episodes attributed to excessive NaCl loss in sweat, particularly during warm weather and in case of digestive losses (20), but it is unknown whether a reduced ability of the CF kidney to retain NaCl contributes to these episodes. In contrast, clearance studies have suggested that CF patients have a decreased natriuretic response to Na+ loading and a reduction in free-water clearance, suggestive of impaired renal diluting capacity (17, 44). Increased PT Na+ reabsorption has been documented in some studies (8, 161) but not in others (4). Patients with CF show an increased renal clearance of aminoglycosides (99), which may be due to impaired megalin uptake (114) and/or altered endocytosis in PT cells (139). The issue remains to be clarified, because renal handling ofTaken together, these data suggest that the putative roles of CFTR
during nephrogenesis, and perhaps in the mature kidney, are probably
complemented by alternative pathways for Cl conduction
(cf. Mouse Models of CF and the Concept of Alternative Pathways
for Cl
Conduction). It must be stressed that subtle
abnormalities in development, function, and/or morphology of the kidney
may remain clinically silent or, alternatively, be associated with
specific, rare mutations of CFTR.
Mouse Models of CF and the Concept of Alternative Pathways for
Cl Conduction
As recently reviewed (59), these mouse models gave
previous information on the pathophysiology of CF in different organs. Except for two strains with a milder disease (45, 178),
the most striking phenotype in the CF mice has been demonstrated in the
intestine, with intestinal blockage and perforation, characteristic pathological changes, and ion transport abnormalities, including a lack
of cAMP-mediated Cl secretion (59). In
addition, CFTR plays an important role in the HCO
An attractive explanation for the discrepancy between human and mouse
CF lung phenotypes is that Cl channel(s) active in mouse
airways may constitute an alternative pathway for Cl
in
the absence of CFTR (31). For instance, the upregulation of a Ca2+-mediated Cl
secretory pathway has
been evidenced in the nasal mucosa of cftrtm1Unc
mice (60) and in the tracheal epithelium of two other CF
mouse models (34, 39). In contrast, intestinal epithelia
lack such apical Ca2+-activated Cl
secretion
(31). It has been suggested that the new family of Ca2+-activated Cl
channels (CaCC or
alternatively named CLCA) may provide the molecular counterpart for
this Ca2+-activated Cl
conductance (53,
79). Other putative candidates to provide apical membrane
Cl
transport in the absence of a functional CFTR include
the voltage-activated ClC-2 (119, 147), ORCC
(54), and a volume-activated Cl
channel
(6, 163). Recent studies have also suggested that ClC-5,
which is expressed during lung ontogeny and localized along the luminal
surface of the airway epithelium, may also participate in lung
Cl
secretion (47). The data summarized
above, which suggest the increased expression of alternative pathways
in the CF mouse, are potentially relevant to all other models of
Cl
channel knockouts because they indicate that the
pathophysiological consequences of the loss of a given Cl
channel pathway can be partially compensated for by the induction of
another. This possibility, which has been documented in the lung of the
CF mice, may apply to other epithelia expessing Cl
channels, including the kidney.
Renal Function in CF Mouse Models
Given the lack of renal manifestations in CF, it is not surprising that there is only limited information about kidney development and function in the CF mouse models (Table 1). The cftrtm1Unc mouse (158) was used to investigate whether CFTR is the molecular counterpart of the 9-pS ClMicropuncture experiments have shown that cAMP stimulates
Cl transport and fluid absorption in rat PT
(185), an effect attributed to the presence of
cAMP-activated Cl
channels in that nephron segment
(1, 149). Kibble et al. (85) investigated PT
function in the
F508 cftrtm2Cam mouse
(34) and showed that renal Na+ clearances
under basal conditions or after acute extracellular volume expansion
are similar in wild-type and
F508 mice. The latter are also
characterized by a lack of increase in glomerular filtration rate
secondary to volume expansion and a relatively less important increase
in proximal Na+ reabsorption than wild-type mice
(85). Despite identification of CFTR expression in the
outer cortex of wild-type mice by RT-PCR, in situ microperfusion showed
that the basal fluid absorptive rate is similar in wild-type and
F508 mice and is not significantly influenced by addition of
forskolin-dibutyryl cAMP to the perfusate. These data may be explained
by a lack of cAMP-dependent whole cell Cl
conductance
evidenced in isolated mouse PT cells (85). In addition, Kibble et al. (86) demonstrated that, under chronic
dietary salt restriction,
F508 mice are equally able to reduce renal Na+ excretion but display a significantly higher
amiloride-sensitive Na+-reabsorption than wild-type mice.
Thus
F508 mice may handle volume expansion and chronic NaCl
restriction similarly to wild-type mice, but that could involve more
distal parts of the nephron (86). The increased
amiloride-sensitive Na+ reabsorption observed in
salt-restricted
F508 mice is consistent with the proposed
interaction between CFTR and ENaC in principal cells of the CD
(98). Accordingly, a reduced inhibition of ENaC in the CD
of
F508 mice could explain the enhanced Na+ absorption
in that nephron segment, which may provide an advantage during states
of salt deprivation. It must be noted, however, that other mechanisms,
such as enhanced secretion of aldosterone, may participate in distal
Na+ reabsorption in salt-restricted mice (58).
The cftrtm2Cam F508 CF mouse
(34) has also been used to investigate the
K+-sparing diuretic effect of glibenclamide. Glibenclamide
blocks native K+ channels in renal cells (10),
but in vitro studies have demonstrated that coexpression of CFTR with
Kir1.1 (ROMK2) is necessary to confer glibenclamide sensitivity on
Kir1.1 channels (112). The fact that glibenclamide induced
an equivalent diuresis and a similar K+-sparing effect in
wild-type and
F508 mice indicates that the formation of Kir1.1/CFTR
complexes is not required to mediate its diuretic effect in mice
(87).
![]() |
CONCLUSIONS AND PERSPECTIVES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Since the first mouse models of CF described in 1992, the
generation of transgenic mice has become an essential tool for
understanding the pathophysiology of Cl channels in the
kidney. This is particularly true for Cl
channels
belonging to the CLC family, which are implicated in selective nephron
segments, where they participate in essential kidney functions such as
endocytosis, NaCl reabsorption, or urinary concentration. There is a
considerable interplay between the characterization of these mouse
models and the discovery of channel diseases in humans. For instance,
the phenotype of patients with Dent's disease due to mutations in
CLCN5 was consistent with a role played by the
Cl
channel ClC-5 in proximal tubule endocytosis
(102), a hypothesis that was indeed verified in two
independent knockout mice lacking ClC-5 (129, 184). The
discovery of mutations in genes coding for ClC-Kb and the
-subunit
barttin not only completed the understanding of genetic heterogeneity
in Bartter's syndrome but also provided key insights into the
regulation of this class of channels (18, 48).
Furthermore, the nephrogenic diabetes insipidus observed in
Clcnk1
/
mice suggests that mutations in
CLCNKA may be responsible for nephrogenic diabetes insipidus
in humans lacking mutations in V2R and AQP2 (172).
There are numerous perspectives for existing and future mouse models
targeting Cl channels. Studies of mice lacking CLC
channels will be important to further define the physiological role of
some of these channels in the kidney and the phenotypical variability
observed in some models. Knockout mice for ClC-k2 or barttin may
provide useful models for Bartter's syndrome and give new information
about the regulation of CLC channels. Gene targeting will also expand
our knowledge of other types of channels that exhibit a
Cl
conductance. An interesting example is aquaporin-6
(AQP6), a member of the aquaporin family of water channels that has
been identified in rat kidney (191). AQP6 is located in
podocytes, PT cells, and
-type intercalated cells of the CD, and it
appears to be mostly associated with intracellular vesicles
(191). The low basal water permeability of AQP6 can be
increased by exposure to mercurials or low pH. Interestingly, the
latter conditions are also reflected by a significant anion conductance
(190). The colocalization of AQP6 with the vacuolar
H+-ATPase in intracellular vesicles, as well as the rapid
and reversible activation of the anion conductance of AQP6 by acidic
pH, led to the suggestion that AQP6 may play a role along other
Cl
channels in vesicle acidification (190).
Further characterization of CF mouse models will certainly be useful to
identify the role of CFTR in specialized kidney functions such as
endocytosis or its interactions with other types of channels and
transporters in the nephron (115, 146). These studies may also be useful in investigating the apparent tissue specificity of
F508 CFTR trafficking (81, 128) and other mechanisms
that could explain the absence of overt renal phenotype in CF. Mating CF mice with other mouse models will also create opportunities to
characterize the role of CFTR in the pathophysiology of renal cyst formation (127). The issue is particularly
relevant in autosomal dominant polycystic kidney disease (ADPKD),
the most common inherited nephropathy. ADPKD is characterized by the
development of multiple cysts in both kidneys, resulting in end-stage
renal disease in 50% of patients by age 60 yr (65).
Genetic studies have shown that ADPKD is due to mutations of two major
genes, PKD1, responsible for ~85% of cases, and
PKD2, which accounts for the vast majority of other cases
(65). Although the complex mechanisms involved in
cystogenesis are not yet understood (27), abnormal fluid secretion is a critical pathogenic mechanism associated with cyst expansion in ADPKD (165). Several lines of evidence have
demonstrated that cAMP-dependent Cl
secretion provides
the driving force for fluid accumulation into ADPKD cysts and that CFTR
is implicated in this process (25, 38, 64). The
availability of mice with targeted disruptions of Pkd1
(104) and Pkd2 (189) may give
insights into this intriguing question.
Finally, one should remain careful about the general limitations of mouse models, including the occurrence of phenotypical variability despite similar genetic backgrounds, the necessity for specific environmental conditions to reveal a phenotype, and the frequent species differences in the structure and function of a given organ (125, 132). However, even these limitations could prove useful because the phenotypical variability of mutant mice according to genetic background underlies the potential importance of genetic modifiers (121). Thus mouse models will also be valuable to investigate disease-modifying genes, an approach that may give insights into complex pathways and provide new therapeutic strategies in renal diseases.
![]() |
ACKNOWLEDGEMENTS |
---|
We thank Prof. R. Beauwens and Prof. P. Courtoy for fruitful discussions.
![]() |
FOOTNOTES |
---|
This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK-32753, the Fondation Alphonse and Jean Forton, the Fondation pour la Recherche Scientifique Medicale, and Actions de Recherche Concertées 00/05-260.
Address for reprint requests and other correspondence: W. B. Guggino, Johns Hopkins Univ. School of Medicine, Depts. of Physiology and Medicine, 725 North Wolfe St., Baltimore, MD 21205 (E-mail: wguggino{at}bs.jhmi.edu).
10.1152/ajprenal.00184.2002
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Abdulnour-Nakhoul, S,
and
Boulpaep EL.
Transcellular chloride pathways in ambystoma proximal tubule.
J Membr Biol
166:
15-35,
1998[ISI][Medline].
2.
Adachi, S,
Uchida S,
Ito H,
Hata M,
Hiroe M,
Marumo F,
and
Sasaki S.
Two isoforms of a chloride channel predominantly expressed in thick ascending limb of Henle's loop and collecting ducts of rat kidney.
J Biol Chem
269:
17677-17683,
1994
3.
Akizuki, N,
Uchida S,
Sasaki S,
and
Marumo F.
Impaired solute accumulation in inner medulla of Clcnk1/
mice kidney.
Am J Physiol Renal Physiol
280:
F79-F87,
2001
4.
Aladjem, M,
Lotan D,
Boichis H,
Orda S,
and
Katznelson D.
Renal function in patients with cystic fibrosis.
Nephron
34:
84-86,
1983[ISI][Medline].
5.
Alper, SL.
The band 3-related anion exchanger (AE) gene family.
Annu Rev Physiol
53:
549-564,
1991[ISI][Medline].
6.
Anderson, MP,
Sheppard DN,
Berger HA,
and
Welsh MJ.
Chloride channels in the apical membrane of normal and cystic fibrosis airway and intestinal epithelia.
Am J Physiol Lung Cell Mol Physiol
263:
L1-L14,
1992
7.
Aniento, F,
Gu F,
Parton RG,
and
Gruenberg J.
An endosomal beta COP is involved in the pH-dependent formation of transport vesicles destined for late endosomes.
J Cell Biol
133:
29-41,
1996[Abstract].
8.
Assael, BM,
Marra G,
Tirelli AS,
Cavanna G,
Claris Appiani A,
Giunta A,
Amoretti M,
and
Milani S.
Renal function in cystic fibrosis.
Int J Pediatr Nephrol
7:
213-216,
1986[ISI][Medline].
9.
Bae, HR,
and
Verkman AS.
Protein kinase A regulates chloride conductance in endocytic vesicles from proximal tubule.
Nature
348:
637-639,
1990[ISI][Medline].
10.
Bailey, MA,
and
Walter SJ.
Renal effects of glibenclamide: a micropuncture study.
J Pharmacol Exp Ther
285:
464-467,
1998
11.
Bailly, C.
Transducing pathways involved in the control of NaCl reabsorption in the thickascending limb of Henle's loop.
Kidney Int
65:
S29-S35,
1998.
12.
Barasch, J,
Kiss B,
Prince A,
Saiman L,
Gruenert D,
and
al-Awqati Q.
Defective acidification of intracellular organelles in cystic fibrosis.
Nature
352:
70-73,
1991[ISI][Medline].
13.
Barg, S,
Huang P,
Eliasson L,
Nelson DJ,
Obermuller S,
Rorsman P,
Thevenod F,
and
Renstrom E.
Priming of insulin granules for exocytosis by granular Cl uptake and acidification.
J Cell Sci
114:
2145-2154,
2001
14.
Beck, L,
Karaplis AC,
Amizuka N,
Hewson AS,
Ozawa H,
and
Tenenhouse HS.
Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities.
Proc Natl Acad Sci USA
95:
5372-5377,
1998
15.
Benharouga, M,
Fritsch J,
Banting G,
and
Edelman A.
Properties of chloride-conductive pathways in rat kidney cortical and outer-medulla brush-border membranesinhibition by anti-(cystic fibrosis transmembrane regulator) mAbs.
Eur J Biochem
246:
367-372,
1997[Abstract].
16.
Bentur, L,
Kerem E,
Couper R,
Baumal R,
Canny G,
Durie P,
and
Levison H.
Renal calcium handling in cystic fibrosis: lack of evidence for a primary renal defect.
J Pediatr
116:
556-560,
1990[ISI][Medline].
17.
Berg, U,
Kusoffsky E,
and
Strandvik B.
Renal function in cystic fibrosis with special reference to the renal sodium handling.
Acta Paediatr Scand
71:
833-838,
1982[ISI][Medline].
18.
Birkenhager, R,
Otto E,
Schurmann MJ,
Vollmer M,
Ruf EM,
Maier-Lutz I,
Beekmann F,
Fekete A,
Omran H,
Feldmann D,
Milford DV,
Jeck N,
Konrad M,
Landau D,
Knoers NV,
Antignac C,
Sudbrak R,
Kispert A,
and
Hildebrandt F.
Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure.
Nat Genet
29:
310-314,
2001[ISI][Medline].
19.
Blaisdell, CJ,
and
Guggino WB.
Anion channels.
In: The Kidney: Physiology and Pathophysiology, edited by Seldin DW,
and Giebisch G.. Philadelphia, PA: Lippincott Williams & Wilkins, 2000, p. 277-291.
20.
Boat, TF.
Cystic fibrosis.
In: Nelson Textbook of Pediatrics (16th ed.), edited by Behrman RE,
Kliegman RM,
and Jenson HB.. Philadelphia, PA: Saunders, 2000, p. 1315-1327.
21.
Bösl, MR,
Stein V,
Hubner C,
Zdebik AA,
Jordt SE,
Mukhopadhyay AK,
Davidoff MS,
Holstein AF,
and
Jentsch TJ.
Male germ cells and photoreceptors, both dependent on close cell-cell interactions, degenerate upon ClC-2 Cl channel disruption.
EMBO J
20:
1289-1299,
2001
22.
Bradbury, NA.
Intracellular CFTR: localization and function.
Physiol Rev
79:
S175-S191,
1999[Medline].
23.
Bradbury, NA,
Jilling T,
Berta G,
Sorscher EJ,
Bridges RJ,
and
Kirk KL.
Regulation of plasma membrane recycling by CFTR.
Science
256:
530-532,
1992[ISI][Medline].
24.
Bradbury, NA,
Jilling T,
Kirk KL,
and
Bridges RJ.
Regulated endocytosis in a chloride secretory epithelial cell line.
Am J Physiol Cell Physiol
262:
C752-C759,
1992
25.
Brill, SR,
Ross KE,
Davidow CJ,
Ye M,
Grantham JJ,
and
Caplan MJ.
Immunolocalization of ion transport proteins in human autosomal dominant polycystic kidney epithelial cells.
Proc Natl Acad Sci USA
93:
10206-10211,
1996
26.
Bushinsky, DA,
Parker WR,
and
Asplin JR.
Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
Kidney Int
57:
550-560,
2000[ISI][Medline].
27.
Calvet, JP,
and
Grantham JJ.
The genetics and physiology of polycystic kidney disease.
Semin Nephrol
21:
107-123,
2001[ISI][Medline].
28.
Choi, JY,
Muallem D,
Kiselyov K,
Lee MG,
Thomas PJ,
and
Muallem S.
Aberrant CFTR-dependent HCO
29.
Christensen, EI,
and
Birn H.
Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule.
Am J Physiol Renal Physiol
280:
F562-F573,
2001
30.
Christensen, EI,
Birn H,
Verroust P,
and
Moestrup SK.
Membrane receptors for endocytosis in the renal proximal tubule.
Int Rev Cytol
180:
237-284,
1998[ISI][Medline].
31.
Clarke, LL,
Grubb BR,
Yankaskas JR,
Cotton CU,
McKenzie A,
and
Boucher RC.
Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr(/
) mice.
Proc Natl Acad Sci USA
91:
479-483,
1994[Abstract].
32.
Clarke, LL,
and
Harline MC.
Dual role of CFTR in cAMP-stimulated HCO
33.
Cleiren, E,
Benichou O,
Van Hul E,
Gram J,
Bollerslev J,
Singer FR,
Beaverson K,
Aledo A,
Whyte MP,
Yoneyama T,
deVernejoul MC,
and
Van Hul W.
Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene.
Hum Mol Genet
10:
2861-2867,
2001
34.
Colledge, WH,
Abella BS,
Southern KW,
Ratcliff R,
Jiang C,
Cheng SH,
MacVinish LJ,
Anderson JR,
Cuthbert AW,
and
Evans MJ.
Generation and characterization of a delta F508 cystic fibrosis mouse model.
Nat Genet
10:
445-452,
1995[ISI][Medline].
35.
Crawford, IT,
and
Maloney PC.
Identification of cystic fibrosis transmembrane conductance regulator in renal endosomes.
Methods Enzymol
292:
652-663,
1998[ISI][Medline].
36.
Crawford, I,
Maloney PC,
Zeitlin PL,
Guggino WB,
Hyde SC,
Turley H,
Gatter KC,
Harris A,
and
Higgins CF.
Immunocytochemical localization of the cystic fibrosis gene product CFTR.
Proc Natl Acad Sci USA
88:
9262-9266,
1991[Abstract].
37.
Cutting, GR.
Cystic fibrosis.
In: Emory and Rimoin's Principle and Practice of Medical Genetics (4th ed.), edited by Rimoin DL,
Connor JM,
Pyeritz RE,
and Korf BR.. London: Churchill Livingstone, 2002, p. 1561-1606.
38.
Davidow, CJ,
Maser RL,
Rome LA,
Calvet JP,
and
Grantham JJ.
The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro.
Kidney Int
50:
208-218,
1996[ISI][Medline].
39.
Delaney, SJ,
Alton EW,
Smith SN,
Lunn DP,
Farley R,
Lovelock PK,
Thomson SA,
Hume DA,
Lamb D,
Porteous DJ,
Dorin JR,
and
Wainwright BJ.
Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype-phenotype correlations.
EMBO J
15:
955-963,
1996[Abstract].
40.
Devuyst, O.
Dietary salt and renal stone disease.
Lancet
349:
507,
1997[ISI][Medline].
41.
Devuyst, O,
Burrow CR,
Schwiebert EM,
Guggino WB,
and
Wilson PD.
Developmental regulation of CFTR expression during human nephrogenesis.
Am J Physiol Renal Fluid Electrolyte Physiol
271:
F723-F735,
1996
42.
Devuyst, O,
Christie PT,
Courtoy PJ,
Beauwens R,
and
Thakker RV.
Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent's disease.
Hum Mol Genet
8:
247-257,
1999
43.
DiGiovanni, SR,
Nielsen S,
Christensen EI,
and
Knepper MA.
Regulation of collecting duct water channel expression by vasopressin in Brattleboro rat.
Proc Natl Acad Sci USA
91:
8984-8988,
1994[Abstract].
44.
Donckerwolcke, RA,
van Diemen-Steenvoorde R,
van der Laag J,
Koomans HA,
and
Boer WH.
Impaired diluting segment chloride reabsorption in patients with cystic fibrosis.
Child Nephrol Urol
12:
186-191,
1992[ISI][Medline].
45.
Dorin, JR,
Dickinson P,
Alton EW,
Smith SN,
Geddes DM,
Stevenson BJ,
Kimber WL,
Fleming S,
Clarke AR,
Hooper ML,
Anderson L,
Beddington RSP,
and
Portgeous DJ.
Cystic fibrosis in the mouse by targeted insertional mutagenesis.
Nature
359:
211-215,
1992[ISI][Medline].
46.
Dutzler, R,
Campbell EB,
Cadene M,
Chait BT,
and
MacKinnon R.
X-ray structure of a ClC chloride channel at 3.0 Å reveals the molecular basis of anion selectivity.
Nature
415:
287-294,
2002[ISI][Medline].
47.
Edmonds, RD,
Silva IV,
Guggino WB,
Butler RB,
Zeitlin PL,
and
Blaisdell CJ.
ClC-5: ontogeny of an alternative chloride channel in respiratory epithelia.
Am J Physiol Lung Cell Mol Physiol
282:
L501-L507,
2002
48.
Estevez, R,
Boettger T,
Stein V,
Birkenhager R,
Otto E,
Hildebrandt F,
and
Jentsch TJ.
Barttin is a Cl channel beta-subunit crucial for renal Cl
reabsorption and inner ear K+ secretion.
Nature
414:
558-561,
2001[ISI][Medline].
49.
Fahlke, C,
Rhodes TH,
Desai RR,
and
George AL, Jr.
Pore stoichiometry of a voltage-gated chloride channel.
Nature
394:
687-690,
1998[ISI][Medline].
50.
Fahlke, C,
Yu HT,
Beck CL,
Rhodes TH,
and
George AL, Jr.
Pore-forming segments in voltage-gated chloride channels.
Nature
390:
529-532,
1997[ISI][Medline].
51.
Fisher, SE,
Black GC,
Lloyd SE,
Hatchwell E,
Wrong O,
Thakker RV,
and
Craig IW.
Isolation and partial characterization of a chloride channel gene which is expressed in kidney and is a candidate for Dent's disease (an X-linked hereditary nephrolithiasis).
Hum Mol Genet
3:
2053-2059,
1994[Abstract].
52.
Friedrich, T,
Breiderhoff T,
and
Jentsch TJ.
Mutational analysis demonstrates that ClC-4 and ClC-5 directly mediate plasma membrane currents.
J Biol Chem
274:
896-902,
1999
53.
Fuller, CM,
Ji HL,
Tousson A,
Elble RC,
Pauli BU,
and
Benos DJ.
Ca2+-activated Cl channels: a newly emerging anion transport family.
Pflügers Arch
443, Suppl1:
S107-S110,
2001[ISI][Medline].
54.
Gabriel, SE,
Clarke LL,
Boucher RC,
and
Stutts MJ.
CFTR and outward rectifying chloride channels are distinct proteins with a regulatory relationship.
Nature
363:
263-268,
1993[ISI][Medline].
55.
Gibson, GA,
Hill WG,
and
Weisz OA.
Evidence against the acidification hypothesis in cystic fibrosis.
Am J Physiol Cell Physiol
279:
C1088-C1099,
2000
56.
Greger, R.
Ion transport mechanisms in thick ascending limb of Henle's loop of mammalian nephron.
Physiol Rev
65:
760-797,
1985
57.
Grubb, BR.
Ion transport across the jejunum in normal and cystic fibrosis mice.
Am J Physiol Gastrointest Liver Physiol
268:
G505-G513,
1995
58.
Grubb, BR,
and
Boucher RC.
Enhanced colonic Na+ absorption in cystic fibrosis mice versus normal mice.
Am J Physiol Gastrointest Liver Physiol
272:
G393-G400,
1997
59.
Grubb, BR,
and
Boucher RC.
Pathophysiology of gene-targeted mouse models for cystic fibrosis.
Physiol Rev
79:
S193-S214,
1999[Medline].
60.
Grubb, BR,
Vick RN,
and
Boucher RC.
Hyperabsorption of Na+ and raised Ca2+-mediated Cl secretion in nasal epithelia of CF mice.
Am J Physiol Cell Physiol
266:
C1478-C1483,
1994
61.
Guinamard, R,
Chraibi A,
and
Teulon J.
A small-conductance Cl channel in the mouse thick ascending limb that is activated by ATP and protein kinase A.
J Physiol
485:
97-112,
1995[Abstract].
62.
Günther, W,
Luchow A,
Cluzeaud F,
Vandewalle A,
and
Jentsch TJ.
ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells.
Proc Natl Acad Sci USA
95:
8075-8080,
1998
63.
Gutknecht, DR.
Kidney stones and cystic fibrosis (Abstract).
Am J Med
111:
83,
2001[ISI][Medline].
64.
Hanaoka, K,
Devuyst O,
Schwiebert EM,
Wilson PD,
and
Guggino WB.
A role for CFTR in human autosomal dominant polycystic kidney disease.
Am J Physiol Cell Physiol
270:
C389-C399,
1996
65.
Harris, PC.
Molecular basis of polycystic kidney disease: PKD1, PKD2 and PKHD1.
Curr Opin Nephrol Hypertens
11:
309-314,
2002[ISI][Medline].
66.
Hasty, P,
O'Neal WK,
Liu KQ,
Morris AP,
Bebok Z,
Shumyatsky GB,
Jilling T,
Sorscher EJ,
Bradley A,
and
Beaudet AL.
Severe phenotype in mice with termination mutation in exon 2 of cystic fibrosis gene.
Somat Cell Mol Genet
21:
177-187,
1995[ISI][Medline].
67.
Higgins, JT, Jr,
Gebler B,
and
Fromter E.
Electrical properties of amphibian urinary bladder epithelia. II. The cell potential profile in Necturus maculosus.
Pflügers Arch
371:
87-97,
1977[ISI][Medline].
68.
Hilpert, J,
Nykjaer A,
Jacobsen C,
Wallukat G,
Nielsen R,
Moestrup SK,
Haller H,
Luft FC,
Christensen EI,
and
Willnow TE.
Megalin antagonizes activation of the parathyroid hormone receptor.
J Biol Chem
274:
5620-5625,
1999
69.
Hoenderop, JG,
Willems PH,
and
Bindels RJ.
Toward a comprehensive molecular model of active calcium reabsorption.
Am J Physiol Renal Physiol
278:
F352-F360,
2000
70.
Hoopes, RR, Jr,
Hueber PA,
Reid RJ, Jr,
Braden GL,
Goodyer PR,
Melnyk AR,
Midgley JP,
Moel DI,
Neu AM,
VanWhy SK,
and
Scheinman SJ.
CLCN5 chloride-channel mutations in six new North American families with X-linked nephrolithiasis.
Kidney Int
54:
698-705,
1998[ISI][Medline].
71.
Horster, M.
Embryonic epithelial membrane transporters.
Am J Physiol Renal Physiol
279:
F982-F996,
2000
72.
Huber, S,
Braun G,
Burger-Kentischer A,
Reinhart B,
Luckow B,
and
Horster M.
CFTR mRNA and its truncated splice variant (TRN-CFTR) are differentially expressed during collecting duct ontogeny.
FEBS Lett
423:
362-366,
1998[ISI][Medline].
73.
Huber, S,
Schroppel B,
Kretzler M,
Schlondorff D,
and
Horster M.
Single cell RT-PCR analysis of ClC-2 mRNA expression in ureteric bud tip.
Am J Physiol Renal Physiol
274:
F951-F957,
1998
74.
Husted, RF,
Volk KA,
Sigmund RD,
and
Stokes JB.
Anion secretion by the inner medullary collecting duct. Evidence for involvement of the cystic fibrosis transmembrane conductance regulator.
J Clin Invest
95:
644-650,
1995[ISI][Medline].
75.
Igarashi, T,
Gunther W,
Sekine T,
Inatomi J,
Shiraga H,
Takahashi S,
Suzuki J,
Tsuru N,
Yanagihara T,
Shimazu M,
Jentsch TJ,
and
Thakker RV.
Functional characterization of renal chloride channel, CLCN5, mutations associated with Dent's Japan disease.
Kidney Int
54:
1850-1856,
1998[ISI][Medline].
76.
Illek, B,
Yankaskas JR,
and
Machen TE.
cAMP and genistein stimulate HCO
77.
Imai, M,
and
Kokko JP.
Sodium chloride, urea, and water transport in the thin ascending limb of Henle. Generation of osmotic gradients by passive diffusion of solutes.
J Clin Invest
53:
393-402,
1974[ISI][Medline].
78.
Imai, M,
Taniguchi J,
and
Tabei K.
Function of thin loops of Henle.
Kidney Int
31:
565-579,
1987[ISI][Medline].
79.
Jentsch, TJ,
Stein V,
Weinreich F,
and
Zdebik AA.
Molecular structure and physiological function of chloride channels.
Physiol Rev
82:
503-568,
2002
80.
Jentsch, TJ,
Steinmeyer K,
and
Schwarz G.
Primary structure of Torpedo marmorata chloride channel isolated by expression cloning in Xenopus oocytes.
Nature
348:
510-514,
1990[ISI][Medline].
81.
Kalin, N,
Claass A,
Sommer M,
Puchelle E,
and
Tummler B.
DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis.
J Clin Invest
103:
1379-1389,
1999
82.
Katz, SM,
Krueger LJ,
and
Falkner B.
Microscopic nephrocalcinosis in cystic fibrosis.
N Engl J Med
319:
263-266,
1988[Abstract].
83.
Kawasaki, M,
Uchida S,
Monkawa T,
Miyawaki A,
Mikoshiba K,
Marumo F,
and
Sasaki S.
Cloning and expression of a protein kinase C-regulated chloride channel abundantly expressed in rat brain neuronal cells.
Neuron
12:
597-604,
1994[ISI][Medline].
84.
Kearns, GL,
Berry PL,
Bocchini JA, Jr,
Hilman BC,
and
Wilson JT.
Renal handling of beta 2-microglobulin in patients with cystic fibrosis.
DICP
23:
1013-1017,
1989[ISI][Medline].
85.
Kibble, JD,
Balloch KJ,
Neal AM,
Hill C,
White S,
Robson L,
Green R,
and
Taylor CJ.
Renal proximal tubule function is preserved in Cftr(tm2cam) deltaF508 cystic fibrosis mice.
J Physiol
532:
449-457,
2001
86.
Kibble, JD,
Neal AM,
Colledge WH,
Green R,
and
Taylor CJ.
Evidence for cystic fibrosis transmembrane conductance regulator-dependent sodium reabsorption in kidney, using Cftr(tm2cam) mice.
J Physiol
526:
27-34,
2000
87.
Kibble, J,
Neal A,
White S,
Green R,
Evans S,
and
Taylor C.
Renal effects of glibenclamide in cystic fibrosis mice.
J Am Soc Nephrol
12:
2507-2510,
2001
88.
Kieferle, S,
Fong P,
Bens M,
Vandewalle A,
and
Jentsch TJ.
Two highly homologous members of the ClC chloride channel family in both rat and human kidney.
Proc Natl Acad Sci USA
91:
6943-6947,
1994[Abstract].
89.
Kishore, BK,
Fuming L,
Maldague P,
Tulkens PM,
and
Courtoy PJ.
Mechanism of the thesaurismosis and altered lysosomal dynamics induced by poly-D-glutamic acid in kidney proximal tubular cells.
Lab Invest
74:
1025-1037,
1996[ISI][Medline].
90.
Knepper, MA,
and
Inoue T.
Regulation of aquaporin-2 water channel trafficking by vasopressin.
Curr Opin Cell Biol
9:
560-564,
1997[ISI][Medline].
91.
Kobayashi, K,
Uchida S,
Mizutani S,
Sasaki S,
and
Marumo F.
Intrarenal and cellular localization of CLC-K2 protein in the mouse kidney.
J Am Soc Nephrol
12:
1327-1334,
2001
92.
Kokko, JP,
and
Rector FC, Jr.
Countercurrent multiplication system without active transport in inner medulla.
Kidney Int
2:
214-223,
1972[ISI][Medline].
93.
Kondo, Y,
Yoshitomi K,
and
Imai M.
Effects of anion transport inhibitors and ion substitution on Cl transport in TAL of Henle's loop.
Am J Physiol Renal Fluid Electrolyte Physiol
253:
F1206-F1215,
1987
94.
Kornak, U,
Kasper D,
Bosl MR,
Kaiser E,
Schweizer M,
Schulz A,
Friedrich W,
Delling G,
and
Jentsch TJ.
Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.
Cell
104:
205-215,
2001[ISI][Medline].
95.
Krivan, HC,
Ginsburg V,
and
Roberts DD.
Pseudomonas aeruginosa and Pseudomonas cepacia isolated from cystic fibrosis patients bind specifically to gangliotetraosylceramide (asialo GM1) and gangliotriaosylceramide (asialo GM2).
Arch Biochem Biophys
260:
493-496,
1988[ISI][Medline].
96.
Lang, F,
Busch GL,
Ritter M,
Volkl H,
Waldegger S,
Gulbins E,
and
Haussinger D.
Functional significance of cell volume regulatory mechanisms.
Physiol Rev
78:
247-306,
1998
97.
Lee, MG,
Choi JY,
Luo X,
Strickland E,
Thomas PJ,
and
Muallem S.
Cystic fibrosis transmembrane conductance regulator regulates luminal Cl/HCO
98.
Letz, B,
and
Korbmacher C.
cAMP stimulates CFTR-like Cl channels and inhibits amiloride-sensitive Na+ channels in mouse CCD cells.
Am J Physiol Cell Physiol
272:
C657-C666,
1997
99.
Levy, J,
Smith AL,
Koup JR,
Williams-Warren J,
and
Ramsey B.
Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study.
J Pediatr
105:
117-124,
1984[ISI][Medline].
100.
Liu, W,
Morimoto T,
Kondo Y,
Iinuma K,
Uchida S,
Sasaki S,
Marumo F,
and
Imai M.
Analysis of NaCl transport in thin ascending limb of Henle's loop in CLC-K1 null mice.
Am J Physiol Renal Physiol
282:
F451-F457,
2002
101.
Lloyd, SE,
Gunther W,
Pearce SH,
Thomson A,
Bianchi ML,
Bosio M,
Craig IW,
Fisher SE,
Scheinman SJ,
Wrong O,
Jentsch TJ,
and
Thakker RV.
Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders.
Hum Mol Genet
6:
1233-1239,
1997
102.
Lloyd, SE,
Pearce SH,
Fisher SE,
Steinmeyer K,
Schwappach B,
Scheinman SJ,
Harding B,
Bolino A,
Devoto M,
Goodyer P,
Rigden SP,
Wrong O,
Jentsch TJ,
Craig IW,
and
Thakker RV.
A common molecular basis for three inherited kidney stone diseases.
Nature
379:
445-449,
1996[ISI][Medline].
103.
Lloyd, SE,
Pearce SH,
Gunther W,
Kawaguchi H,
Igarashi T,
Jentsch TJ,
and
Thakker RV.
Idiopathic low molecular weight proteinuria associated with hypercalciuric nephrocalcinosis in Japanese children is due to mutations of the renal chloride channel (CLCN5).
J Clin Invest
99:
967-974,
1997
104.
Lu, W,
Peissel B,
Babakhanlou H,
Pavlova A,
Geng L,
Fan X,
Larson C,
Brent G,
and
Zhou J.
Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation.
Nat Genet
17:
179-181,
1997[ISI][Medline].
105.
Ludewig, U,
Pusch M,
and
Jentsch TJ.
Two physically distinct pores in the dimeric ClC-0 chloride channel.
Nature
383:
340-343,
1996[ISI][Medline].
106.
Lukacs, GL,
Chang XB,
Kartner N,
Rotstein OD,
Riordan JR,
and
Grinstein S.
The cystic fibrosis transmembrane regulator is present and functional in endosomes. Role as a determinant of endosomal pH.
J Biol Chem
267:
14568-14572,
1992
107.
Luyckx, VA,
Goda FO,
Mount DB,
Nishio T,
Hall A,
Hebert SC,
Hammond TG,
and
Yu AS.
Intrarenal and subcellular localization of rat CLC5.
Am J Physiol Renal Physiol
275:
F761-F769,
1998
108.
Luyckx, VA,
Leclercq B,
Dowland LK,
and
Yu AS.
Diet-dependent hypercalciuria in transgenic mice with reduced CLC5 chloride channel expression.
Proc Natl Acad Sci USA
96:
12174-12179,
1999
109.
Marvao, P,
De Jesus Ferreira MC,
Bailly C,
Paulais M,
Bens M,
Guinamard R,
Moreau R,
Vandewalle A,
and
Teulon J.
Cl absorption across the thick ascending limb is not altered in cystic fibrosis mice. A role for a pseudo-CFTR Cl
channel.
J Clin Invest
102:
1986-1993,
1998
110.
Masilamani, S,
Knepper MA,
and
Burg MB.
Urine concentration and dilution.
In: The Kidney (6th ed.), edited by Brenner BM.. Philadelphia, PA: Saunders, 2000, p. 595-635.
111.
Matsumura, Y,
Uchida S,
Kondo Y,
Miyazaki H,
Ko SB,
Hayama A,
Morimoto T,
Liu W,
Arisawa M,
Sasaki S,
and
Marumo F.
Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel.
Nat Genet
21:
95-98,
1999[ISI][Medline].
112.
McNicholas, CM,
Guggino WB,
Schwiebert EM,
Hebert SC,
Giebisch G,
and
Egan ME.
Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound glibenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator.
Proc Natl Acad Sci USA
93:
8083-8088,
1996
113.
Mellman, I,
Fuchs R,
and
Helenius A.
Acidification of the endocytic and exocytic pathways.
Annu Rev Biochem
55:
663-700,
1986[ISI][Medline].
114.
Moestrup, SK,
Cui S,
Vorum H,
Bregengard C,
Bjorn SE,
Norris K,
Gliemann J,
and
Christensen EI.
Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs.
J Clin Invest
96:
1404-1413,
1995[ISI][Medline].
115.
Mohammad-Panah, R,
Ackerley C,
Rommens J,
Choudhury M,
Wang Y,
and
Bear CE.
The chloride channel ClC-4 co-localizes with cystic fibrosis transmembrane conductance regulator and may mediate chloride flux across the apical membrane of intestinal epithelia.
J Biol Chem
277:
566-574,
2002
116.
Morales, MM,
Carroll TP,
Morita T,
Schwiebert EM,
Devuyst O,
Wilson PD,
Lopes AG,
Stanton BA,
Dietz HC,
Cutting GR,
and
Guggino WB.
Both the wild-type and a functional isoform of CFTR are expressed in kidney.
Am J Physiol Renal Fluid Electrolyte Physiol
270:
F1038-F1048,
1996
117.
Morales, MM,
Nascimento DS,
Capella MA,
Lopes AG,
and
Guggino WB.
Arginine vasopressin regulates CFTR and ClC-2 mRNA expression in rat kidney cortex and medulla.
Pflügers Arch
443:
202-211,
2001[ISI][Medline].
118.
Morello, JP,
and
Bichet DG.
Nephrogenic diabetes insipidus.
Annu Rev Physiol
63:
607-630,
2001[ISI][Medline].
119.
Murray, CB,
Chu S,
and
Zeitlin PL.
Gestational and tissue-specific regulation of C1C-2 chloride channel expression.
Am J Physiol Lung Cell Mol Physiol
271:
L829-L837,
1996
120.
Murray, CB,
Morales MM,
Flotte TR,
McGrath-Morrow SA,
Guggino WB,
and
Zeitlin PL.
ClC-2: a developmentally dependent chloride channel expressed in the fetal lung and downregulated after birth.
Am J Respir Cell Mol Biol
12:
597-604,
1995[Abstract].
121.
Nadeau, JH.
Modifier genes in mice and humans.
Nat Rev Genet
2:
165-174,
2001[ISI][Medline].
122.
Obermuller, N,
Gretz N,
Kriz W,
Reilly RF,
and
Witzgall R.
The swelling-activated chloride channel ClC-2, the chloride channel ClC-3, and ClC-5, a chloride channel mutated in kidney stone disease, are expressed in distinct subpopulations of renal epithelial cells.
J Clin Invest
101:
635-642,
1998
123.
O'Neal, WK,
Hasty P,
McCray PB, Jr,
Casey B,
Rivera-Perez J,
Welsh MJ,
Beaudet AL,
and
Bradley A.
A severe phenotype in mice with a duplication of exon 3 in the cystic fibrosis locus.
Hum Mol Genet
2:
1561-1569,
1993[Abstract].
124.
Ornellas, DS,
Nascimento DS,
Christoph DH,
Guggino WB,
and
Morales MM.
Aldosterone and high-NaCl diet modulate ClC-2 chloride channel gene expression in rat kidney.
Pflügers Arch
444:
193-201,
2002[ISI][Medline].
125.
Pearson, H.
Surviving a knockout blow.
Nature
415:
8-9,
2002[ISI][Medline].
126.
Perez-Brayfield, MR,
Caplan D,
Gatti JM,
Smith EA,
and
Kirsch AJ.
Metabolic risk factors for stone formation in patients with cystic fibrosis.
J Urol
167:
480-484,
2002[ISI][Medline].
127.
Persu, A,
and
Devuyst O.
Transepithelial chloride secretion and cystogenesis in autosomal dominant polycystic kidney disease.
Nephrol Dial Transplant
15:
747-750,
2000
128.
Persu, A,
Devuyst O,
Lannoy N,
Materne R,
Brosnahan G,
Gabow PA,
Pirson Y,
and
Verellen-Dumoulin C.
CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease.
J Am Soc Nephrol
11:
2285-2296,
2000
129.
Piwon, N,
Gunther W,
Schwake M,
Bosl MR,
and
Jentsch TJ.
ClC-5 Cl channel disruption impairs endocytosis in a mouse model for Dent's disease.
Nature
408:
369-373,
2000[ISI][Medline].
130.
Poschet, JF,
Skidmore J,
Boucher JC,
Firoved AM,
Van Dyke RW,
and
Deretic V.
Hyperacidification of cellubrevin endocytic compartments and defective endosomal recycling in cystic fibrosis respiratory epithelial cells.
J Biol Chem
277:
13959-13965,
2002
131.
Quinton, PM.
The neglected ion: HCO
132.
Rao, S,
and
Verkman AS.
Analysis of organ physiology in transgenic mice.
Am J Physiol Cell Physiol
279:
C1-C18,
2000
133.
Ratcliff, R,
Evans MJ,
Cuthbert AW,
MacVinish LJ,
Foster D,
Anderson JR,
and
Colledge WH.
Production of a severe cystic fibrosis mutation in mice by gene targeting.
Nat Genet
4:
35-41,
1993[ISI][Medline].
134.
Reenstra, WW,
Sabolic I,
Bae HR,
and
Verkman AS.
Protein kinase A dependent membrane protein phosphorylation and chloride conductance in endosomal vesicles from kidney cortex.
Biochemistry
31:
175-181,
1992[ISI][Medline].
135.
Reinhart, SC,
Norden AG,
Lapsley M,
Thakker RV,
Pang J,
Moses AM,
Frymoyer PA,
Favus MJ,
Hoepner JA,
and
Scheinman SJ.
Characterization of carrier females and affected males with X-linked recessive nephrolithiasis.
J Am Soc Nephrol
5:
1451-1461,
1995[Abstract].
136.
Rosenstein, BJ,
and
Zeitlin PL.
Cystic fibrosis.
Lancet
351:
277-282,
1998[ISI][Medline].
137.
Rozmahel, R,
Wilschanski M,
Matin A,
Plyte S,
Oliver M,
Auerbach W,
Moore A,
Forstner J,
Durie P,
Nadeau J,
Bear C,
and
Tsui LC.
Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor.
Nat Genet
12:
280-287,
1996[ISI][Medline].
138.
Sakamoto, H,
Sado Y,
Naito I,
Kwon TH,
Inoue S,
Endo K,
Kawasaki M,
Uchida S,
Nielsen S,
Sasaki S,
and
Marumo F.
Cellular and subcellular immunolocalization of ClC-5 channel in mouse kidney: colocalization with H+-ATPase.
Am J Physiol Renal Physiol
277:
F957-F965,
1999
139.
Samaniego-Picota, MD,
and
Whelton A.
Aminoglycoside-induced nephrotoxicity in cystic fibrosis: a case presentation and review of the literature.
Am J Ther
3:
248-257,
1996[Medline].
140.
Sasaki, S,
and
Yoshiyama N.
Interaction of chloride and bicarbonate transport across the basolateral membrane of rabbit proximal straight tubule.
J Clin Invest
81:
1004-1011,
1988[ISI][Medline].
141.
Scheinman, SJ.
X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations.
Kidney Int
53:
3-17,
1998[ISI][Medline].
142.
Scheinman, SJ,
Guay-Woodford LM,
Thakker RV,
and
Warnock DG.
Genetic disorders of renal electrolyte transport.
N Engl J Med
340:
1177-1187,
1999
143.
Schmid, A,
Burckhardt G,
and
Gogelein H.
Single chloride channels in endosomal vesicle preparations from rat kidney cortex.
J Membr Biol
111:
265-275,
1989[ISI][Medline].
144.
Schmidt-Rose, T,
and
Jentsch TJ.
Transmembrane topology of a CLC chloride channel.
Proc Natl Acad Sci USA
94:
7633-7638,
1997
145.
Schwake, M,
Friedrich T,
and
Jentsch TJ.
An internalization signal in ClC-5, an endosomal Cl channel mutated in Dent's disease.
J Biol Chem
276:
12049-12054,
2001
146.
Schwiebert, EM,
Benos DJ,
Egan ME,
Stutts MJ,
and
Guggino WB.
CFTR is a conductance regulator as well as a chloride channel.
Physiol Rev
79:
S145-S166,
1999[Medline].
147.
Schwiebert, EM,
Cid-Soto LP,
Stafford D,
Carter M,
Blaisdell CJ,
Zeitlin PL,
Guggino WB,
and
Cutting GR.
Analysis of ClC-2 channels as an alternative pathway for chloride conduction in cystic fibrosis airway cells.
Proc Natl Acad Sci USA
95:
3879-3884,
1998
148.
Schwiebert, EM,
Egan ME,
Hwang TH,
Fulmer SB,
Allen SS,
Cutting GR,
and
Guggino WB.
CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP.
Cell
81:
1063-1073,
1995[ISI][Medline].
149.
Seki, G,
Taniguchi S,
Uwatoko S,
Suzuki K,
and
Kurokawa K.
Activation of the basolateral Cl conductance by cAMP in rabbit renal proximal tubule S3 segments.
Pflügers Arch
430:
88-95,
1995[ISI][Medline].
150.
Seksek, O,
Biwersi J,
and
Verkman AS.
Evidence against defective trans-Golgi acidification in cystic fibrosis.
J Biol Chem
271:
15542-15548,
1996
151.
Sheppard, DN,
and
Welsh MJ.
Structure and function of the CFTR chloride channel.
Physiol Rev
79:
S23-S45,
1999[Medline].
152.
Shi, LB,
Fushimi K,
Bae HR,
and
Verkman AS.
Heterogeneity in ATP-dependent acidification in endocytic vesicles from kidney proximal tubule. Measurement of pH in individual endocytic vesicles in a cell-free system.
Biophys J
59:
1208-1217,
1991[Abstract].
153.
Shimkets, RA,
Lifton RP,
and
Canessa CM.
The activity of the epithelial sodium channel is regulated by clathrin-mediated endocytosis.
J Biol Chem
272:
25537-25541,
1997
154.
Silva, IV,
Blaisdell CJ,
Guggino SE,
and
Guggino WB.
PTH regulates expression of ClC-5 chloride channel in the kidney.
Am J Physiol Renal Physiol
278:
F238-F245,
2000
155.
Simon, DB,
Bindra RS,
Mansfield TA,
Nelson-Williams C,
Mendonca E,
Stone R,
Schurman S,
Nayir A,
Alpay H,
Bakkaloglu A,
Rodriguez-Soriano J,
Morales JM,
Sanjad SA,
Taylor CM,
Pilz D,
Brem A,
Trachtman H,
Griswold W,
Richard GA,
John E,
and
Lifton RP.
Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III.
Nat Genet
17:
171-178,
1997[ISI][Medline].
156.
Simon, DB,
Karet FE,
Hamdan JM,
DiPietro A,
Sanjad SA,
and
Lifton RP.
Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2.
Nat Genet
13:
183-188,
1996[ISI][Medline].
157.
Simon, DB,
Karet FE,
Rodriguez-Soriano J,
Hamdan JH,
DiPietro A,
Trachtman H,
Sanjad SA,
and
Lifton RP.
Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK.
Nat Genet
14:
152-156,
1996[ISI][Medline].
158.
Snouwaert, JN,
Brigman KK,
Latour AM,
Malouf NN,
Boucher RC,
Smithies O,
and
Koller BH.
An animal model for cystic fibrosis made by gene targeting.
Science
257:
1083-1088,
1992[ISI][Medline].
159.
Stanton, BA.
Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.
Wien Klin Wochenschr
109:
457-464,
1997[ISI][Medline].
160.
Steinmeyer, K,
Schwappach B,
Bens M,
Vandewalle A,
and
Jentsch TJ.
Cloning and functional expression of rat CLC-5, a chloride channel related to kidney disease.
J Biol Chem
270:
31172-31177,
1995
161.
Stenvinkel, P,
Hjelte L,
Alvan G,
Hedman A,
Hultman E,
and
Strandvik B.
Decreased renal clearance of sodium in cystic fibrosis.
Acta Paediatr Scand
80:
194-198,
1991[ISI][Medline].
162.
Stobrawa, SM,
Breiderhoff T,
Takamori S,
Engel D,
Schweizer M,
Zdebik AA,
Bosl MR,
Ruether K,
Jahn H,
Draguhn A,
Jahn R,
and
Jentsch TJ.
Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus.
Neuron
29:
185-196,
2001[ISI][Medline].
163.
Strange, K,
Emma F,
and
Jackson PS.
Cellular and molecular physiology of volume-sensitive anion channels.
Am J Physiol Cell Physiol
270:
C711-C730,
1996
164.
Stutts, MJ,
Canessa CM,
Olsen JC,
Hamrick M,
Cohn JA,
Rossier BC,
and
Boucher RC.
CFTR as a cAMP-dependent regulator of sodium channels.
Science
269:
847-850,
1995[ISI][Medline].
165.
Sullivan, LP,
Wallace DP,
and
Grantham JJ.
Epithelial transport in polycystic kidney disease.
Physiol Rev
78:
1165-1191,
1998
166.
Takahashi, N,
Chernavvsky DR,
Gomez RA,
Igarashi P,
Gitelman HJ,
and
Smithies O.
Uncompensated polyuria in a mouse model of Bartter's syndrome.
Proc Natl Acad Sci USA
97:
5434-5439,
2000
167.
Tauc, M,
Bidet M,
and
Poujeol P.
Chloride currents activated by calcitonin and cAMP in primary cultures of rabbit distal convoluted tubule.
J Membr Biol
150:
255-273,
1996[ISI][Medline].
168.
Thiemann, A,
Grunder S,
Pusch M,
and
Jentsch TJ.
A chloride channel widely expressed in epithelial and non-epithelial cells.
Nature
356:
57-60,
1992[ISI][Medline].
169.
Traebert, M,
Roth J,
Biber J,
Murer H,
and
Kaissling B.
Internalization of proximal tubular type II Na-Pi cotransporter by PTH: immunogold electron microscopy.
Am J Physiol Renal Physiol
278:
F148-F154,
2000
170.
Traebert, M,
Volkl H,
Biber J,
Murer H,
and
Kaissling B.
Luminal and contraluminal action of 1-34 and 3-34 PTH peptides on renal type IIa Na-Pi cotransporter.
Am J Physiol Renal Physiol
278:
F792-F798,
2000
171.
Trezise, AE,
Chambers JA,
Wardle CJ,
Gould S,
and
Harris A.
Expression of the cystic fibrosis gene in human foetal tissues.
Hum Mol Genet
2:
213-218,
1993[Abstract].
172.
Uchida, S.
In vivo role of CLC chloride channels in the kidney.
Am J Physiol Renal Physiol
279:
F802-F808,
2000
173.
Uchida, S,
Sasaki S,
Furukawa T,
Hiraoka M,
Imai T,
Hirata Y,
and
Marumo F.
Molecular cloning of a chloride channel that is regulated by dehydration and expressed predominantly in kidney medulla.
J Biol Chem
268:
3821-3824,
1993
174.
Uchida, S,
Sasaki S,
Fushimi K,
and
Marumo F.
Isolation of human aquaporin-CD gene.
J Biol Chem
269:
23451-2355,
1994
175.
Uchida, S,
Sasaki S,
Nitta K,
Uchida K,
Horita S,
Nihei H,
and
Marumo F.
Localization and functional characterization of rat kidney-specific chloride channel, ClC-K1.
J Clin Invest
95:
104-113,
1995[ISI][Medline].
176.
Vandewalle, A,
Cluzeaud F,
Bens M,
Kieferle S,
Steinmeyer K,
and
Jentsch TJ.
Localization and induction by dehydration of ClC-K chloride channels in the rat kidney.
Am J Physiol Renal Physiol
272:
F678-F688,
1997
177.
Vandewalle, A,
Cluzeaud F,
Peng KC,
Bens M,
Luchow A,
Gunther W,
and
Jentsch TJ.
Tissue distribution and subcellular localization of the ClC-5 chloride channel in rat intestinal cells.
Am J Physiol Cell Physiol
280:
C373-C381,
2001
178.
Van Doorninck, JH,
French PJ,
Verbeek E,
Peters RH,
Morreau H,
Bijman J,
and
Scholte BJ.
A mouse model for the cystic fibrosis delta F508 mutation.
EMBO J
14:
4403-4411,
1995[Abstract].
179.
Vandorpe, D,
Kizer N,
Ciampollilo F,
Moyer B,
Karlson K,
Guggino WB,
and
Stanton BA.
CFTR mediates electrogenic chloride secretion in mouse inner medullary collecting duct (mIMCD-K2) cells.
Am J Physiol Cell Physiol
269:
C683-C689,
1995[Abstract].
180.
Van Kuijck, MA,
van Aubel RA,
Busch AE,
Lang F,
Russel FG,
Bindels RJ,
van Os CH,
and
Deen PM.
Molecular cloning and expression of a cyclic AMP-activated chloride conductance regulator: a novel ATP-binding cassette transporter.
Proc Natl Acad Sci USA
93:
5401-5406,
1996
181.
Van Slegtenhorst, MA,
Bassi MT,
Borsani G,
Wapenaar MC,
Ferrero GB,
de Conciliis L,
Rugarli EI,
Grillo A,
Franco B,
Zoghbi HY,
and
Ballabio A.
A gene from the Xp22.3 region shares homology with voltage-gated chloride channels.
Hum Mol Genet
3:
547-552,
1994[Abstract].
182.
Van Weert, AW,
Dunn KW,
Gueze HJ,
Maxfield FR,
and
Stoorvogel W.
Transport from late endosomes to lysosomes, but not sorting of integral membrane proteins in endosomes, depends on the vacuolar proton pump.
J Cell Biol
130:
821-834,
1995[Abstract].
183.
Waldegger, S,
and
Jentsch TJ.
From tonus to tonicity: physiology of CLC chloride channels.
J Am Soc Nephrol
11:
1331-1339,
2000
184.
Wang, SS,
Devuyst O,
Courtoy PJ,
Wang XT,
Wang H,
Wang Y,
Thakker RV,
Guggino S,
and
Guggino WB.
Mice lacking renal chloride channel, ClC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis.
Hum Mol Genet
9:
2937-2945,
2000
185.
Wang, T,
Segal AS,
Giebisch G,
and
Aronson PS.
Stimulation of chloride transport by cAMP in rat proximal tubules.
Am J Physiol Renal Fluid Electrolyte Physiol
268:
F204-F210,
1995
186.
Welsh, MJ,
Ramsey BW,
Accurso F,
and
Cutting GR.
Cystic fibrosis.
In: The Metabolic and Molecular Bases of Inherited Disease, edited by Scriver CR,
Beaudet AL,
Sly WS,
and Valle D.. New York: McGraw-Hill, 2001, p. 5121-5188.
187.
Welsh, MJ,
and
Smith AE.
Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis.
Cell
73:
1251-1254,
1993[ISI][Medline].
188.
Wrong, OM,
Norden AG,
and
Feest TG.
Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance.
Q J Med
87:
473-493,
1994[ISI].
189.
Wu, G,
D'Agati V,
Cai Y,
Markowitz G,
Park JH,
Reynolds DM,
Maeda Y,
Le TC,
Hou H, Jr,
Kucherlapati R,
Edelmann W,
and
Somlo S.
Somatic inactivation of Pkd2 results in polycystic kidney disease.
Cell
93:
177-188,
1998[ISI][Medline].
190.
Yasui, M,
Hazama A,
Kwon TH,
Nielsen S,
Guggino WB,
and
Agre P.
Rapid gating and anion permeability of an intracellular aquaporin.
Nature
402:
184-187,
1999[ISI][Medline].
191.
Yasui, M,
Kwon TH,
Knepper MA,
Nielsen S,
and
Agre P.
Aquaporin-6: an intracellular vesicle water channel protein in renal epithelia.
Proc Natl Acad Sci USA
96:
5808-5813,
1999
192.
Yoshikawa, M,
Uchida S,
Yamauchi A,
Miyai A,
Tanaka Y,
Sasaki S,
and
Marumo F.
Localization of rat CLC-K2 chloride channel mRNA in the kidney.
Am J Physiol Renal Physiol
276:
F552-F558,
1999
193.
Yoshitomi, K,
Kondo Y,
and
Imai M.
Evidence for conductive Cl pathways across the cell membranes of the thin ascending limb of Henle's loop.
J Clin Invest
82:
866-871,
1988[ISI][Medline].
194.
Yu, AS.
Role of ClC-5 in the pathogenesis of hypercalciuria: recent insights from transgenic mouse models.
Curr Opin Nephrol Hypertens
10:
415-420,
2001[ISI][Medline].
195.
Zeiher, BG,
Eichwald E,
Zabner J,
Smith JJ,
Puga AP,
McCray PB, Jr,
Capecchi MR,
Welsh MJ,
and
Thomas KR.
A mouse model for the delta F508 allele of cystic fibrosis.
J Clin Invest
96:
2051-2064,
1995[ISI][Medline].
196.
Zimniak, L,
Winters CJ,
Reeves WB,
and
Andreoli TE.
Cl channels in basolateral renal medullary vesicles. X. Cloning of a Cl
channel from rabbit outer medulla.
Kidney Int
48:
1828-1836,
1995[ISI][Medline].